Recent data has shown that DCs expressing PD-L1 correlate with CD8+ T cell infiltration and good prognosis in colon cancer [194], and improved efficacy of anti-PD-1 treatment in ovarian cancer and melanoma [195]. This evidence concerns the gene CD8A and melanoma.